Articles

Financial Times Article: Big Pharma Aims for Reinvention

Big Pharma Aims For Reinvention

The Financial Times

 By Andrew Jack 5/13/2010 5:30 AM

Summary:

 

Reported that for many years, large pharmaceutical companies have relied on a handful of “blockbusters” that generate billions of dollars a year in sales, but as patents expire on drugs such as Lipitor, big pharma is having to rethink its business model.

New Alarm Bells About Chemicals and Cancer

from The New York Times, May 5, 2010

New Alarm Bells About Chemicals and Cancer
Nicholas D. Kristof

The Estrogen Dilemma

From The New York Times Magazine, April 12, 1020

The Estrogen Dilemma
by Cynthia Gorney

U.S. Panel Criticized as Overstating Cancer Risks

The New York Times

From The New York Times, May 6, 2010

U.S. Panel Criticized as Overstating Cancer Risks
by Denise Grady

Obama should have second thoughts about deals with drug companies 09/03/2009

By Erika Schwartz, MD, Kent Holtorf MD and David Brownstein MD

The summer recess is allowing Congress to gauge first-hand the public’s rising concern for the cost and substance of the proposed healthcare reform. The concern, however, does not seem to be shared in Washington by the Administration and its new fast friends – the drug companies.

AMA doesn't represent doctors, or their patients' best interests

The American Medical Association has shown where its loyalties lie – and it’s not with America’s doctors or their patients.

Instead the AMA has demonstrated yet again it is bought-and-paid-for tool of the pharmaceutical industry.

At its annual meeting in Chicago this week, the AMA decided there is “evidence” that long-term use of Human Growth Hormone can present more risks than benefits and that bioidentical hormones are no safer than traditional estrogen and progesterone products.

Well, thanks for the warning guys.

AMA Adopts New Policy Against Anti-Aging Hormones

 

The AMA doesn't represent doctors, or their patients' best interests

The American Medical Association has shown where its loyalties lie – and it’s not with America’s doctors or their patients.

Instead the AMA has demonstrated yet again it is a bought-and-paid-for tool of the pharmaceutical industry.

BHI Welcomes You!

Find out here what interests you and have your say. We look forward to your feedback, interests, and suggestions

Pages

Resources

BHI Online houses an archive of hormone-related citations for biomedical literature. Also provided are links to PubMed and the NCBI molecular biology resources.
Read more...

Webinars

BHI Online strives to support healthcare professionals through webinars presented by leading experts in their respective fields.
Read more...

Forums

Join the conversation with BHI Online's forums aimed at providing information through communities.
Read more...

Latest News

A selection of stories and articles making headlines in the field of Bioidentical Hormone therapies.
Read more...

Get In Touch

Locate a BHRT doctor, submit an article or just say hello, we'd love to meet you.
Read more...

Sub Page: Side Block 1

Sub Page: Side Block 2

Sub Page: Side Block 3

Sub Page: Side Block 4